After Advent's Felix Pharma buyout, another deal is brewing in the vet medicine segment. Multiples and other investors of ...

The data from 2019 to 2023 show rapid uptake of the drugs alongside wide patient- and practice-level variations.

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a narrow economic moat. Growth of existing products and new product launches should help offset ...

Investing.com -- Wells Fargo (NYSE: WFC) has initiated coverage of Zealand Pharma (NASDAQ: ZEAL) with an Overweight rating ...

Sen. Tim Kaine has been involved with bringing pharmaceutical reseach and development to central Virginia since his days on ...

A recent study reveals only a handful of individuals globally achieve billionaire status before 30, primarily through ...

It's shaping up to be a big year for Boehringer Ingelheim—at least if the FDA plays ball. | Boehringer Chief Medical Officer ...

People's brains aged faster during the COVID-19 pandemic whether they were infected or not, serial imaging data from the U.K.

THE German-Philippine Chamber of Commerce and Industry (GPCCI), in partnership with the German Embassy-Manila and Boehringer Ingelheim Philippines, convened a multi-stakeholder roundtable to address ...

Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data across more than 100 ...